News
Tirzepatide (Zepbound) came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial ...
Amid the chaos of the Battle of Arnhem in September 1944, Major Digby, a fearless British paratrooper, stood out with an unconventional weapon in hand. Like a true British gentleman, the Major carried ...
The Trump administration on Monday singled out powerful new weight-loss drugs including Wegovy and Zepbound as targets in its ...
The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...
A new study found users of one drug lost almost 50 percent more weight that users of Wegovy. People taking Eli Lilly’s ...
The popular weight loss medications produced different results in patients who participated in a trial, and here’s what ...
CVS Caremark decided to stop offering one product in favor of another for weight loss, the latest example of ...
The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.
A new study shows Zepbound beats Wegovy for weight loss. "It's NOT normal to snore; get it checked out. Sleep apnea worsens ...
A new study has found that people taking Eli Lilly's obesity drug Zepbound lost almost 50% more weight than those using Novo ...
The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.
Eli Lilly announced that its obesity therapy Zepbound delivered superior outcomes versus Novo Nordisk’s Wegovy across five ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results